Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHENOL DERIVATIVE
Document Type and Number:
Japanese Patent JPH10195037
Kind Code:
A
Abstract:

To obtain a new phenol derivative capable of suppressing formation of foam cell of macrophage by excellent anti-oxidant action and ACAT inhibition action to suppress progress of arteriosclerosis, eliminating active oxygen and suppressing cell injury, etc., in cardiac infarction, ischemia/reperfusion.

This compound is represented by a compound of formula I [R0 is H, a (substituted)alkyl or a (substituted)alkyloxy; R1 is a (substituted) alkyl; R2 is R1 or a (substituted)alkyloxy; OR3 is a (protected)hydroxyl group; R4 is H, a (substituted)lower alkyl or acyl; W is O, S or NR7 is H, an alkyl, etc.); R5 and R6 are each a (substituted)alkyl, a (substituted)amino, etc., e.g. 2-[3-(3-pyridylmethyl)ureido]-4-methoxy-6-tert-butylphenol. The compound of formula I is obtained by reacting, e.g. a compound (reactive derivative) of formula II [OR31 is a (protected)-hydroxy group; W1 is O or S] with an amine compound (salt) of the formula, HNR5R6.


Inventors:
SUZUKI RIICHI
OMIZU HIROSHI
HASHIMURA YOSHIMASA
KUBOTA HITOSHI
SAITO KEIKO
Application Number:
JP2858297A
Publication Date:
July 28, 1998
Filing Date:
February 13, 1997
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TANABE SEIYAKU CO
International Classes:
A61K31/17; A61K31/195; A61K31/215; A61K31/27; A61K31/357; A61K31/36; A61K31/40; A61K31/403; A61K31/404; A61K31/415; A61K31/4166; A61K31/4184; A61K31/44; A61K31/4402; A61K31/4406; A61K31/4409; A61K31/4418; A61K31/4425; A61K31/4427; A61K31/445; A61K31/4465; A61K31/454; A61K31/47; A61K31/472; A61K31/495; A61K31/496; A61K31/535; A61K31/5355; A61K31/5375; A61K31/55; A61P3/06; A61P9/06; A61P9/08; A61P9/10; A61P43/00; C07C273/02; C07C275/34; C07C277/08; C07C279/18; C07C335/18; C07D209/08; C07D211/34; C07D213/40; C07D243/08; C07D213/66; C07D213/73; C07D213/74; C07D213/75; C07D215/38; C07D217/06; C07D223/12; C07D231/06; C07D233/38; C07D233/64; C07D235/08; C07D235/14; C07D239/50; C07D295/12; C07D295/18; C07D295/20; C07D295/22; C07D317/58; C07D401/12; C07D403/12; (IPC1-7): C07C275/34; C07C273/02; C07C277/08; C07C279/18; C07C335/18; C07D211/34; C07D213/40; C07D213/66; C07D213/73; C07D213/74; C07D213/75; C07D217/06; C07D223/12; C07D231/06; C07D233/38; C07D233/64; C07D235/08; C07D235/14; C07D239/50; C07D243/08; C07D295/12; C07D295/18; C07D295/20; C07D295/22; C07D317/58; C07D401/12; C07D403/12
Attorney, Agent or Firm:
Shigeo Minoura